Stenosing tenosynovitis, or trigger finger, commonly encountered by primary care physicians, orthopaedic surgeons, and hand specialists, may respond to any of a number of nonoperative measures, including activity modification, nonsteroidal anti-inflammatory drugs, splinting, and corticosteroid injections. Long-acting corticosteroid injection has become the primary method of initial treatment for the symptomatic trigger finger, with a high reported rate of success, particularly in patients without diabetes with the involvement of a single digit and a short duration of symptoms. Injections of corticosteroids into the flexor tendon sheath are believed to work by reducing tenosynovial swelling and also A-1 pulley thickening to decrease the mismatch between the volume of the flexor tendon sheath and its contents so that the flexor tendon no longer catches in a stenotic sheath. Many different injection techniques and corticosteroid preparations have been reported.
Such data will help providers and patients make informed decisions on the choice of nonoperative or operative measures to treat this commonly encountered problem. 
